Skip to main content

Intercure Ltd.

INCR
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001857030

No open-market purchases or sales by Intercure Ltd. insiders were filed in the last 90 days; 16 institutions reported holding it in 13F filings for Q2 2026, worth $764.1K in total; no superinvestor holds it.

Holders of 5% or more of INCR

Holders whose latest Schedule 13D or 13G filing reports 5% or more of Intercure Ltd., largest stake first. The change is against the holder's previous filing.

Holders of 5% or more of INCR
HolderLatest formStakeChangeFirst filedLatest filingFiling
Rabinovich Alexander13D29.40%16.8M sharesNewDec 9, 20251 filingDec 9, 2025SEC

Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.

13D and 13G filings

1 Schedule 13D or 13G filing on Intercure Ltd., newest first, including old-format filings without a stake.

Schedule 13D and 13G filings on INCR
Filed (ET)FilerFormStakeChangeEvent dateFiling
Dec 9, 202511:24 AM ETRabinovich Alexanderand 1 other13D29.40%16.8M sharesNewMar 2, 2025SEC

Form 144: proposed insider sales

Notices from officers, directors and other affiliates planning to sell Intercure Ltd. shares.

No Form 144 notices for Intercure Ltd. are on file.